Drugmaker Bristol-Myers Squibb Co. (NYSE: BMY) and Asterand PLC are extending a research collaboration for up to three years, according to Associated Press on Monday.
Asterand, with offices in Detroit and the United Kingdom, will continue to provide drug discovery services and human tissue and clinical samples to Bristol-Myers Squibb. The tissue and samples will be used in research on potential drugs. The companies entered a three-year partnership in May 2007.
Get Rich Penny Stocks is a leading financial publication that is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter
Financial terms weren't disclosed.
In morning trading, shares of Bristol-Myers Squibb rose 42 cents to $24.88. Earlier, the New York company's stock set an annual high of $24.92.
Sign up for the Free GetRichPennyStocks Newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
GetRichPennyStocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that could be on the brink of a breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
